Intellectual Property (IP), Artificial Intelligence (AI), Open Movements (OM)

My Bloomsbury book "Ethics, Information, and Technology" was published on Nov. 13, 2025. Purchases can be made via Amazon and this Bloomsbury webpage: https://www.bloomsbury.com/us/ethics-information-and-technology-9781440856662/

Showing posts with label access to medicines. Show all posts

Wednesday, November 30, 2016

Summer Project Turns Into Leukemia Testing Breakthrough; New York Times, 11/28/16

›

Donald G. McNeil Jr., New York Times; Summer Project Turns Into Leukemia Testing Breakthrough : 'Gleevec, which made almost $5 billion ...

Wednesday, May 25, 2016

Unaffordable Medicines Now Global Issue; System Needs Change, Panellists Say; Intellectual Property Watch,

›

Catherine Saez, Intellectual Property Watch; Unaffordable Medicines Now Global Issue; System Needs Change, Panellists Say : "At a side...

Wednesday, April 13, 2016

Lifting the Patent Barrier to New Drugs and Energy Sources; New York Times, 4/12/16

›

Eduardo Porter, New York Times; Lifting the Patent Barrier to New Drugs and Energy Sources : "Malaria has preyed on humans for centuri...

Monday, July 25, 2011

Parliament Study: ACTA Not Fully In Line With EU Rules; Intellectual Property Watch, 7/20/11

›

Monika Ermert, Intellectual Property Watch; Parliament Study: ACTA Not Fully In Line With EU Rules : "The Anti-Counterfeiting Trade Agr...

›

Home

View web version

About Me

Kip Currier, PhD, JD: Assistant Professor, University of Pittsburgh School of Computing and Information. Education: PhD, University of Pittsburgh School of Information Sciences (2007); Juris Doctor (JD), University of Pittsburgh School of Law; Master of Library and Information Science (MLIS), University of Pittsburgh School of Information Sciences. Member of American Bar Association (ABA), ABA IP Law Section, ABA Science & Technology Section

View my complete profile